Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Martin Kast

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Cancer Letters|June 10, 2011
Notch-ing from T-cell to B-cell lymphoid malignanciesLeonardo Mirandola, Paola Comi, Everardo Cobos, et al.
Immunological Reviews|March 28, 2008
A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive settingAndrew Gray, Adam B Raff, Maurizio Chiriva-Internati, et al.
Cancer Research|May 13, 2010
Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regressionShreya Kanodia, Diane M Da Silva, Tigran Karamanukyan, et al.
Cancer Research|February 5, 2008
Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunityMaria de la Luz Garcia-Hernandez, Andrew Gray, Bolyn Hubby, et al.
Human Vaccines & Immunotherapeutics|February 3, 2016
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseasesJoseph G Skeate, Andrew W Woodham, Mark H Einstein, et al.
The Journal of General Virology|June 6, 2015
A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumoursLies Bogaert, Andrew W Woodham, Diane M Da Silva, et al.
International Reviews of Immunology|May 12, 2011
Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapiesMaurizio Chiriva-Internati, Leonardo Mirandola, W Martin Kast, et al.
Cancer Immunology, Immunotherapy : CII|December 24, 2005
T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cellsGretchen E Lyons, Jeffrey J Roszkowski, Stephen Man, et al.
Papillomavirus Research (Amsterdam, Netherlands)|November 29, 2017
Syndemic synergy of HPV and other sexually transmitted pathogens in the development of high-grade anal squamous intraepithelial lesionsJenny C McCloskey, W Martin Kast, James P Flexman, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
HPV protein/peptide vaccines: from animal models to clinical trialsSteven C Fausch, Diane M Da Silva, Gretchen L Eiben, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Cancer Letters|June 10, 2011
Notch-ing from T-cell to B-cell lymphoid malignanciesLeonardo Mirandola, Paola Comi, Everardo Cobos, et al.
Immunological Reviews|March 28, 2008
A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive settingAndrew Gray, Adam B Raff, Maurizio Chiriva-Internati, et al.
Cancer Research|May 13, 2010
Expression of LIGHT/TNFSF14 combined with vaccination against human papillomavirus Type 16 E7 induces significant tumor regressionShreya Kanodia, Diane M Da Silva, Tigran Karamanukyan, et al.
Cancer Research|February 5, 2008
Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunityMaria de la Luz Garcia-Hernandez, Andrew Gray, Bolyn Hubby, et al.
Human Vaccines & Immunotherapeutics|February 3, 2016
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseasesJoseph G Skeate, Andrew W Woodham, Mark H Einstein, et al.
The Journal of General Virology|June 6, 2015
A novel murine model for evaluating bovine papillomavirus prophylactics/therapeutics for equine sarcoid-like tumoursLies Bogaert, Andrew W Woodham, Diane M Da Silva, et al.
International Reviews of Immunology|May 12, 2011
Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapiesMaurizio Chiriva-Internati, Leonardo Mirandola, W Martin Kast, et al.
Cancer Immunology, Immunotherapy : CII|December 24, 2005
T-cell receptor tetramer binding or the lack there of does not necessitate antigen reactivity in T-cell receptor transduced T cellsGretchen E Lyons, Jeffrey J Roszkowski, Stephen Man, et al.
Papillomavirus Research (Amsterdam, Netherlands)|November 29, 2017
Syndemic synergy of HPV and other sexually transmitted pathogens in the development of high-grade anal squamous intraepithelial lesionsJenny C McCloskey, W Martin Kast, James P Flexman, et al.
Frontiers in Bioscience : a Journal and Virtual Library|November 29, 2002
HPV protein/peptide vaccines: from animal models to clinical trialsSteven C Fausch, Diane M Da Silva, Gretchen L Eiben, et al.
Pageof 14